Today the Nasdaq is one of the world’s leading stock exchanges. It’s second only to the New York Stock Exchange (NYSE). But when it was founded in 1971 by the National Association of Securities Dealers (NASD), the “National Association of Securities Dealers Automated Quotations” was just a quotation system and didn’t actually trade stocks.
The Nasdaq officially separated from the NASD and began to operate as a national securities exchange in 2006. In the early stages, it included a lot of stocks that traded as speculative over-the-counter (OTC) issues.
But as the Exchange became the first U.S. stock market to start trading online, it attracted new tech companies who saw it as a more modern, more dynamic place to list their stocks. Those companies included, Apple, Cisco, Dell, Microsoft and Oracle and a host of others.
The exchange’s heavy weighting toward tech and other “riskier” issues lets investors use it as a barometer of how much risk investors are willing to take on at any one time. The Nasdaq also offers a pre-market session from 4:00 am to 9:30 am Eastern, a normal trading session from 9:30 am to 4:00 pm, and a post-market session from 4:00 pm to 8:00 pm.
There are currently more than 3,000 equities listed on the exchange, many of them in the tech sector.
To learn more about the Nasdaq, the NYSE, and other exchanges, as well as how to get started investing in them, download our FREE report, How to Invest in Stocks and Other Investing Basics. It has all the information you need to start investing on your own today. And it costs you absolutely nothing. Download it right now and start your journey to investing success.
Stock Recommendation Tracker
The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to...
Read More
Stock Recommendation Tracker
The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to...
Read More
This may just go down on record as one of the worst earnings seasons ever for growth stocks. Two weeks ago, things were “fine.” Since May began, not. Inflation is the bogeyman spooking investors and his shadow has crept out from below desks up...
Read More
BioLife Solutions (BLFS) reported yesterday afternoon and Q1 results beat expectations. Revenue was up 38.6% to $16.9 million (beating by $800K) while adjusted EPS of $0.01 beat by a penny. Management also bumped up full-year guidance, with revenue now expected in the $106 to million...
Read More
In this week's video, Mike Cintolo talks about the still-soggy environment, with growth stocks remaining in corrections while more of the broad market has come under some pressure.
Read More
This week’s main theme was follow-on selling from last week’s mess, with most growth stocks remaining under pressure and (at least during the first three days of the week) the selling spreading to other nooks and crannies of the market.
Read More
This has been another tough week for most growth-oriented small cap stocks as the sellers have clearly taken control. There are easy targets to point to as driving the decline, namely fear of inflation. But the reality is it is mostly just a of...
Read More
Remain defensive. Growth stocks remain under severe pressure, and today notwithstanding, that selling is starting to spread to the broad market (our Cabot Tides are on the fence).
Read More
Fears of rising inflation hammered Wall Street this week so today we are selling two lagging positions and adding a blue chip inflation hedge.
Read More
It looks like the relentless bull market is finally running into trouble. The market indexes are down a lot for the third straight day.
Read More
Recent days have seen substantial selling pressures in the broad market, with growth stocks being particularly hard hit. But the good news is that stocks in the marijuana sector, which had previously corrected 50% from their February peak to their bottom in late or...
Read More
The market remains in the dumps, and while some beaten-down growth names have found support, many are still getting hit on earnings and we’re even seeing selling spread to the broad market.
Read More
We’ve seen signs of it everywhere. Retail prices for homes, apartments, food, gasoline, cars and everyday services are higher than they were a year or two ago and are going higher. Upstream from these consumer-facing prices, input prices for raw materials, semiconductors, crops, energy...
Read More
This is an unusual environment to say the least. The market is looking ahead to the highest GDP growth in decades as vaccines end the lockdowns and restrictions. And forecasts continue to rise. At the same time, trillions in government stimulus will flood the...
Read More
Pent-Up Demand
I recently stumbled upon the below chart showing that savings rates in 2020 were 50% to 500% higher than the previous 20 years.
What is the takeaway? There is plenty of pent-up demand around the world. In other words, people have money burning hole...
Read More
EVBG, KRNT and CRNC Report. Sell GSHD and CDLX
Read More
As market volatility returns, the most volatile stocks today aren't worth the risk. Here are three to avoid; one of them will surprise you.
Read More
The Cabot Profit Booster portfolio continues to be in the right stocks, even as sector rotation intensifies and countless stocks have come under intense selling pressure. This is a great situation, and sparked a great question from a CPB subscriber:
Read More
With the Dow hitting another new high but the growth-focused Nasdaq Composite still unable to get above its February peak, we remain in a bull market that is challenging for growth investors; in fact, many recent great earnings reports have been met with instead...
Read More
There have been a lot of failed stock breakouts, suggesting the bears are in charge. But there's reason to be encouraged by the big picture.
Read More
